D.W. Kim

Statistics

Publications

Citations

482

H-Index

Active since

2004

Affiliations

University of Colorado Anschutz Medical Campus(Current)

D.W. Kim is an author at University of Colorado Anschutz Medical Campus specializing in anaplastic lymphoma kinase inhibition, lung cancer, and non-small cell lung cancer treatment.

Publications per year

2004–2018

Publications

Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study

Shirish M. Gadgeel, Solange Peters, Tony Mok et al. · Annals of Oncology · 2018 · 324 citations · Full text

Medicine, Oncology, Pharmacology +17

The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons

Sangmi Chung, Eva Hedlund, Moon‐Hyon Hwang et al. · Molecular and Cellular Neuroscience · 2004 · 147 citations · Full text

Life Sciences, Developmental Biology, Neuroscience +16

3101 Updated efficacy and safety results from a global phase 2, open-label, single-arm study (NP28673) of alectinib in crizotinib-refractory ALK+ non-small-cell lung cancer (NSCLC)

Fabrice Barlési, Anne‐Marie C. Dingemans, I. Ou et al. · European Journal of Cancer · 2015 · 11 citations

Medicine, Oncology, Pharmacology +16

1–3 of 3